CureVac NV (MIL:1CVAC)
€ 3.238 0.118 (3.78%) Market Cap: 682.29 Mil Enterprise Value: 167.50 Mil PE Ratio: 5.91 PB Ratio: 0.92 GF Score: 33/100

Q4 2023 CureVac NV Earnings Call Transcript

Apr 24, 2024 / 01:00PM GMT
Release Date Price: €2.26 (-5.36%)
Operator

Greetings, and welcome to the CureVac fourth-quarter and full year 2023 financial results and business update conference call. (Operator Instructions) Please note this conference is being recorded.

I will now turn the conference over to your host, Sarah Fakih. You may begin.

Sarah Fakih
CureVac NV - Vice President - Corporate Communications and Investor Relations

Thank you. Good morning, good afternoon, and welcome to our conference call. My name is Sarah Fakih, and I'm the Vice President of Corporate Communications and Investor Relations at CureVac. Please let me introduce today's speakers.

On the call with me from CureVac are Alexander Zehnder, Chief Executive Officer of CureVac; Myriam Mendila, our Chief Development Officer; and Pierre Kemula, Chief Financial Officer of CureVac. So Head of Intellectual Properties, Marcus Dalton will be present for the Q&A session.

Please note that this call is being webcast live and will be archived on the events and presentations section under investor relations on our website.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot